EUCTR2004-001126-24-BE进行中（未招募）1 期
Feasibility of radiotherapy and concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma
niversity Hospital Ghent0 个研究点目标入组 30 人开始时间: 2005年12月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •* Histological proven and unresectable adenocarcinoma of the pancreas or cholangiocarcinoma with no evidence of metastatic disease.
- •* WHO performance status 0-1
- •* Adequate bone marrow reserve.
- •* No previous chemotherapy or radiotherapy.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •* Previous or co-existent malignant disease except non melanoma skin cancers and adequately treated cervix carcinoma in situ.
- •* Active infection.
- •* Metastatic disease.
- •* Inadequate renal or liver function.
- •* Pregnancy.
- •* Use of any other investigational agent in the month before enrolment into the study.
- •* Age < 18 years.
研究者
相似试验
已完成
2 期
Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal CholangiocarcinomaLocally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or CholangiocarcinomaNCT00286013University Hospital, Ghent24
招募中
2 期
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
进行中（未招募）
不适用
ow-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study - NDadvanced and/or metastatic NSCLCMedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastaticEUCTR2008-003690-40-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
招募中
1 期
Feasibility study of concurrent chemoradiotherapy with docetaxel and cisplatin for head and neck cancer in the elderly or mild renal dysfunction -Multicenter studyhead and neck cancerJPRN-UMIN000009270Department of Otolaryngology-Head and Neck Surgery, Osaka University School of Medicine30
进行中（未招募）
1 期
eoadjuvant Radiochemotherapy Combined with Panitumumab in Locally Advanced KRAS wild-type Rectal Cancer - NeoRec-1Histologically confirmed, potentially resectable rectal adenocarcinoma staged as uT3/4, N0/1 by endosonography or cT3/4 by MRI of the pelvis with or without local lymph node metastases, but without evidence of distant metastases.MedDRA version: 13.1Level: LLTClassification code 10038052Term: Rectal carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-009277-10-DEniversity Hospital Heidelberg48